Company Description
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.
The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries.
It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support.
In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions.
It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies.
The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.
Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 2016 |
| Industry | Information Technology Services |
| Sector | Technology |
| Employees | 12,000 |
| CEO | Matitiahu Shem Tov |
Contact Details
Address: 70 St. Mary Axe London, EC3A 8BE United Kingdom | |
| Phone | 44 20 7433 4000 |
| Website | clarivate.com |
Stock Details
| Ticker Symbol | CLVT |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1764046 |
| CUSIP Number | G21810109 |
| ISIN Number | JE00BJJN4441 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Matitiahu Shem Tov | Chief Executive Officer and Director |
| Jonathan M. Collins | Executive Vice President and Chief Financial Officer |
| Gordon Samson | President of Intellectual Property |
| Bar Veinstein | President of Academia and Government |
| Henry Levy | President of Life Sciences and Healthcare |
| Michael Easton | Senior Vice President of Finance and Chief Accounting Officer |
| William E. Graff | Executive Vice President and Chief Information Officer |
| Mark J. Donohue CPA | Head of Investor Relations |
| John Doulamis | Senior Vice President and General Counsel |
| Tabita Andersson | Senior Vice President of Communications and Brand |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 24, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Feb 6, 2026 | SCHEDULE 13D/A | Filing |
| Feb 3, 2026 | 8-K | Current Report |
| Feb 2, 2026 | 8-K | Current Report |
| Dec 1, 2025 | 144 | Filing |
| Nov 4, 2025 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Oct 29, 2025 | 10-Q | Quarterly Report |
| Oct 29, 2025 | 8-K | Current Report |
| Sep 10, 2025 | 144 | Filing |